期刊文献+

八珍汤加味联合化疗治疗中晚期肺癌24例临床观察 被引量:6

Clinical observation of Bazhen decoction combined with chemotherapy on advanced lung cancer
下载PDF
导出
摘要 目的观察八珍汤加味联合化疗治疗中晚期肺癌的临床疗效及不良反应。方法将48例中晚期肺癌患者随机分为2组,治疗组24例采用八珍汤加味联合GP(注射用盐酸吉西他滨+顺铂注射液)方案化疗治疗,对照组24例单纯采用GP方案化疗治疗。2组均治疗2个周期后观察临床疗效、生活质量及不良反应。结果治疗组有效(RR)率62.5%,对照组RR率50.0%,治疗组RR率高于对照组(P<0.05),治疗组疗效优于对照组。治疗组总改善率83.4%,对照组总改善率50.0%,治疗组总改善率高于对照组(P<0.05),治疗组生活质量优于对照组。治疗组不良反应发生率低于对照组(P<0.05)。结论八珍汤加味联合化疗治疗中晚期肺癌,能提高化疗有效率,减轻不良反应,降低化疗对中晚期肺癌患者免疫功能的影响,提高生活质量。 Objective To observe the clinical effect and side effect of Bazhen decoction combined with chemotherapy on advanced lung cancer.Methods 48 patients with advanced lung cancer patients were randomly divided into two groups.24 patients in treatment group were treated by Bazhen decoction combined with GP chemotherapy regimen.24 cases in control group received simple GP treatment regimen.Results The effective rate in treatment group was higher than that in the control group(P0.05).The total improvement rate in treatment group was higher than that in the control group(P0.05),quality of life in the treatment group was more than that in the control group.The incidence of adverse in treatment group was less than that in the control group(P0.05).Conclusion Bazhen decoction combined with chemotherapy can enhance effective rate of chemotherapy,relieve adverse reaction and improve life quality on advanced lung cancer.
出处 《河北中医》 2011年第8期1170-1171,共2页 Hebei Journal of Traditional Chinese Medicine
关键词 八珍汤 抗肿瘤联合化疗方案 肺肿瘤 中西医结合疗法 化学疗法 辅助 Bazhen decoction Anti-tumor combined with chemotherapy program Lung neoplasms Integrated Chinese and western medicine Chemotherapy Assistance
  • 相关文献

参考文献5

二级参考文献15

  • 1侯安继,陈友香,项荣.扶正消癌Ⅰ号方治疗中晚期上消化道恶性肿瘤的临床研究[J].中国中西医结合消化杂志,2004,12(6):332-334. 被引量:12
  • 2李凤云,张永恒,于桂兰,吴玉波,孙世忠.十全大补冲剂对肿瘤化疗药物增效减毒作用的研究[J].肿瘤,1996,16(1):38-40. 被引量:25
  • 3李航,潘立群.中药联合新辅助化疗治疗进展期胃癌的临床研究[J].江苏中医药,2006,27(3):25-27. 被引量:6
  • 4胡志萍,甘宁.陈焕朝治疗肺癌经验[J].四川中医,2007,25(5):7-8. 被引量:12
  • 5Scagliotti G. Optimizing chemotherapy for patients with advanced non-small cell lung cancer[ J ]. J Thorac Oncol,2007,2 (Suppl 2) :S86.
  • 6Devlin JG, Langer CJ. Salvage therapy with vinorelbine in advanced non-small-cell lung cancer: a retrospective review of the Fox Chase Cancer Center experience and a review of the literature[ J]. Clin Lung Cancer,2007,8 (5) :319.
  • 7Sekine I, Nokihara H, Sumi M, et al. Docetaxel consolidation therapy following cisplatin ,vinorelbine, and concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancer [ J ]. Thorac Oncol,2006,1 (8) :810.
  • 8Hirsh V, Desjardins P, Needles BM, et al. Oral versus intravenous administration of vinorelbine as a single agent for the first-line treatment of metastatic nonsmall cell lung carcinoma ( NSCLC ) : A randomized phase Ⅱ trial[J]. Am J Clln Oncol,2007,30(3) :245.
  • 9张代钊.中医药对肿瘤放化疗的增效减毒作用[J].中国中西医结合杂志,1992,12(3):135-135.
  • 10黄家驷 吴阶平.外科学[M].北京:人民卫生出版社,1999.601.

共引文献118

同被引文献92

引证文献6

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部